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Th e incidence of diabetes mellitus (DM) is increasing rapidly and it is expected to increase by 2030. Other than currently available 
therapeutic options, there are a lot of herbal medicines, which have been recommended for its treatment. Herbal medicines have 
long been used for the treatment of DM because of the advantage usually having no or less side-eﬀ ects. Most of these plants have 
antioxidant activities and hence, prevent or treat hard curable diseases, other than having the property of combating the toxicity of 
toxic or other drugs. In this review other than presenting new ﬁ ndings of DM, the plants, which are used and have been evaluated 
scientiﬁ cally for the treatment of DM are introduced.
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hard curable diseases, other than having the property 
of combating the toxicity of toxic[14,15] or other drugs.[16-19] 
In this review other than presenting new fi ndings of 
DM the plants which are used for the treatment of DM 
are introduced.
DIFFERENT FORMS OF DIABETES MELLITUS
There are several types of DM, three main types of 
them are type 1, type 2 and gestational diabetes. 
Type 1 diabetes mellitus “juvenile diabetes or insulin-
dependent diabetes mellitus” results from the pancreas 
failure to produce insulin, and requires the patients 
to use insulin. Type 2 DM “adult-onset diabetes or 
noninsulin-dependent diabetes mellitus results from 
insulin resistance, a condition in which cells cannot 
use insulin properly. Gestational diabetes occurs when 
pregnant women develop a high blood glucose level 
without a previous diagnosis of diabetes. This kind of 
diabetes may precede the development of type 2 DM. 
Other forms of DM include steroid diabetes induced 
by high doses of glucocorticoids, congenital diabetes, 
which is due to genetic defects of insulin secretion, 
cystic fi brosis-related diabetes, and several forms of 
monogenic diabetes.[1-7]
DIABETES MELLITUS COMPLICATIONS
The patients with DM are at increased risk of 
complications such as peripheral vascular disease, 
retinopathy, nephropathy, neuropathy, coronary heart 
INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic disorders 
in which the blood sugar is higher than normal level 
either because the production of insulin is not enough 
(type 1 DM) or the cells do not properly respond to the 
insulin (type 2 DM).[1]
According to a report from World Health Organization, 
about 220 million people have type 2 DM. Its incidence 
is increasing rapidly, and it is expected to increase to 
more than 365 million by 2030.[2] DM occurs throughout 
the world. However, it is more common in the more 
developed countries. It is noteworthy that the highest 
increase in prevalence is expected to occur in Africa and 
Asia.[3] The increase in incidence in developing countries 
follows the trend of urbanization and lifestyle changes, 
perhaps most importantly a “Western-style” diets.[3]
Other than currently available therapeutic options, 
there are a lot of herbal medicines, which have 
been recommended for the treatment of DM,[4,5] 
hyperlipidemia[4-7] and other cardiovascular risk 
factors.[4-9]
Herbal medicines have long been used for the treatment 
of DM. This is because such herbal plants have 
hypoglycemic properties and other benefi cial eﬀ ects. 
Herbal medicines have the advantage of usually having 
no or less side-eﬀ ects.[10,11] Most of these plant have 
antioxidant activities[12,13] and hence, prevent or treat 
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disease. The exact causes of type 2 diabetes are still need to 
be clear.[1-7] DM increases the risk of complications, which 
may develop aĞ er 10-20 years, however, may be the fi rst 
symptom in patients who have not diagnosed before that 
time. The major long-term complications are related to 
damage to blood vessels. DM approximately doubles the 
risk of cardiovascular diseases. The main “macro-vascular” 
diseases are peripheral vascular disease, angina, myocardial 
infarction and stroke.[1-7,20]
Diabetes mellitus damages the capillaries causing micro-
angiopathy. Diabetic retinopathy, which aﬀ ects blood vessel 
in the eye retina, causes visual symptoms including reduced 
vision and blindness.[21-23] Diabetic nephropathy usually 
leads to changes in the kidney tissue, loss of progressively 
larger amounts of protein in the urine and chronic kidney 
disease.[21-24]
Diabetic neuropathy commonly causes tingling, numbness 
and pain in the feet. It also increases the risk of skin damage 
due to altered sensation. Vascular complications in the legs 
contribute to the risk of diabetes-related foot problems such 
as diabetic foot ulcers that might be diﬃ  cult to treat and 
occasionally require amputation.[5,21-24]
Compared to the subjects without diabetes, those with the 
disease have about 1.5-fold greater rate of defi cit in cognitive 
function, and herbal medicines with hypoglycemic activities 
have been shown to counteract this complication.[21-26]
DIABETES MELLITUS PATHOGENESIS
The cause of diabetes depends on the type of DM. Type 
1 is, at least in part, inherited. It may also be triggered by 
certain toxins or infections. In patients susceptibility to 
some of these triggers a genetic element has been traced 
to particular HLA genotypes. However, even in patients 
genetically susceptible, type 1 DM usually requires an 
environmental trigger. In contrast to type 1 DM in which 
its onset is unrelated to lifestyle, type 2 DM is primarily due 
to lifestyle factors other than genetics. The most important 
lifestyle factors, which are known to be involved in the 
development of type 2 DM include: Urbanization, poor 
diet, lack of physical activity, stress, and obesity or body 
mass index of >30.[1-4]
Dietary factors also seem to have infl uence on development 
of type 2 DM. Consumption of drinks sweetened in 
excess increases the risk of type 2 DM. Trans faĴ y acids 
and saturated fats also increase the risk. In contrast 
monounsaturated and polyunsaturated fat decrease the 
risk.[1,5,27,28] Lack of exercise dramatically increases the risk 
of cases.[1,5,27,28]
DIABETES MELLITUS MANAGEMENT
There is no known cure for DM except in very specifi c 
situations. Management of DM concentrates mostly on 
keeping blood sugar to normal levels as possible, which 
is usually accomplished with exercise, diet, and use of 
appropriate medications.[1,5,27,28]
The complications of diabetes are less common and less 
severe in patients who have well-managed blood sugar 
levels. Therefore, patient participation is vital. The goal of 
treatment is keeping an HbA1C level of 6.5%, however, it 
should not be less than that.[1,5,27-29] AĴ ention should also be 
paid to other factors which may accelerate the deleterious 
eﬀ ects of diabetes, including elevated cholesterol level, 
obesity, high blood pressure, smoking, and lack of regular 
exercise.[27-29]
Several lines of medications are used in the treatment of MD 
[Table 1]. The current used therapies for type-2 DM include 
sulfonylureas, biguanides, inhibitors of a-glucosidase, 
thiazolidinediones, and inhibitors of dipeptidyl peptidase-4. 
Metformin is generally used as fi rst line treatment for type 
2 DM, as it has shown to decrease mortality rate.[30] When 
blood sugar is very high and insulin is used in type 2 
diabetes, usually a long-acting drug is added initially, while 
continuing oral medications Type 1 DM is typically treated 
with synthetic insulin and usually a combination of regular 
and NPH insulin.[30]
Table 1: Oral anti-diabetic drugs currently available for the treatment of diabetes mellitus
Drug group Mechanism Example Side effects
Sulfonylureas/insulinotropics Inhibiting of KATP channels and 
increase in insulin release
Glibenclamide, Glipizide, 
Chlorpropamide, Tolbutamide
Hypoglycemia, Weight gain
Biguanides Increase in insulin sensitivity 
and reduce hepatic glucose 
production
a-Glucosidase inhibitors Inhibition 
of carbohydrate digestion and 
absorption
Thiazolidinediones Activation of 
peroxisome proliferator-activated 
receptor gamma and improvement 
of insulin action
Metformin Diarrhea, nausea, abdominal 
pain, Lactic acidosis
Metallic taste Acarbose 
Rosiglitazone
Ddiarrhea, abdominal cramping, 
ﬂ atulence Hepatoxicity
DPP-4 inhibitors (Gliptins) Inhibition of DPP-4 and reduction 
of glucagon and blood glucose
Sitagliptin, Vildagliptin, Saxagliptin, 
Linagliptin
Nasopharyngitis, Headache, Nausea, 
Hypersensitivity, Skin reaction
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The available synthetic drugs for the treatment of 
DM mostly are expensive and produce serious side 
effects [Table 1]. Hence, safer and more effective anti-
diabetic drugs are urgently needed. Nowadays medicinal 
plants with antioxidant activity have been on the focus 
of the researchers for their hypoglycemic activities[31] 
or for reduction of the side-effects of hypoglycemic 
drugs.[31-33]
ANTIOXIDANT AND OTHER THERAPIES
As the pathogenesis of DM involves oxidative stress, 
antioxidant therapies should have a potential value in its 
treatment. Many trials in animal models of diabetes and 
diabetic patients have aĴ empted to determine the role of 
antioxidant therapy on prevention or treatment of diabetes 
complications.[32-34]
Furthermore, signifi cant increase in endogenous prooxidant 
activity and decrease in antioxidants has been shown 
to contribute to the oxidative stress in diabetes. A 
marked decrease in glutathione peroxidase (GSHPx) 
and superoxide dismutase (SOD) activities have been 
reported in diabetic animals.[30-34] Treatment with probucol, 
which has antioxidant activity resulted in a signifi cant 
improvement in myocardial activities of catalase, SOD 
and GSHPx (antioxidant enzymes) providing evidence 
that diabetic cardiomyopathy was associated with an 
antioxidant defi cit.[30-35] Overexpression of catalase in STZ-
treated transgenic mice aĴ enuated the onset of diabetic 
complications, indicating the therapeutic potential of 
catalase.[32-36]
Several pharmacologic agents effective in reducing 
diabetic mortalities have been shown to have antioxidant 
activities. For example, 3-hydroxy-3-methylglutaryl 
coenzyme A reductase inhibitors, angiotensin-converting 
enzyme (ACE) inhibitors or statins have benefi cial eﬀ ects 
on diabetic patients[30-37] that may involve antioxidant 
eﬀ ects. Interestingly, ACE inhibitors, which act partially 
to prevent the prooxidant effects of angiotensin II, 
were shown to prevent the onset of type 2 diabetes.[32-38] 
Vitamin E supplementation has been associated with a 
signifi cant decline in protein oxidation, lipid peroxidation 
and enhancement in the antioxidant defense system. 
Vitamin E may promote benefi cial eﬀ ects on diabetic 
complications through the attenuation of oxidative 
stress.[35-39]
Peroxynitrite and other reactive species can also induce 
oxidative DNA damage. Inhibitors of specifi c components 
of ROS-sensitive signaling cascades such as CGP53353 and 
ruboxistaurin, which are specifi c inhibitors of protein kinase 
C, are able to aĴ enuate hyperglycemia-induced vascular cell 
adhesion molecule-1 expression and nuclear factor-kappa-B 
activation in human aortic endothelial cells.[30-40]
Coenzyme Q10, a lipid-soluble antioxidant, has been 
shown to scavenge superoxide and improve endothelial 
function in diabetes. Caﬀ eic acid phenethyl ester (CAPE), 
a fl avonoid-like compound, has an ameliorating eﬀ ect on 
oxidative stress in cardiac tissue via its antioxidant property, 
indicating that CAPE should be considered for preventing 
oxidative stress in the diabetic heart.[36-41]
Medicinal plants with antioxidant activities have also been 
shown to be protective in diabetic rats by scavenging oxygen 
free radicals and decreasing the expressions of intercellular 
cell adhesion molecule-1 protein.[35-42]
CLINICAL PERSPECTIVES OF ANTIOXIDANT 
THERAPY
Despite several experimental studies suggesting 
beneficial effects antioxidants in reduction of diabetes 
complications, results from clinical trials on beneficial 
eﬀ ects of traditional antioxidants such as Vitamin E or C 
have been disappointing.[40-43] A meta-analysis of clinical 
trials, studying Vitamin E therapy suggests that the use of 
high-dose Vitamin E (greater than 400 IU/day) may actually 
increase mortality ;[41-44] however, this fi nding has been 
questioned.[42-45] Zinc and melatonin in combination with a 
regularly used metformin have been shown to signifi cantly 
reduce fasting glucose and glycated hemoglobin levels 
in patients with type 2 diabetes.[43-46] However, not all 
studies supported this notion. Several studies indicated no 
improvement in the glucose metabolism in either type 1 or 
type 2 diabetic patients aĞ er zinc treatment.[44-47]
These contradictory results may have emerged from 
a variety of factors, such as patient diversity and zinc 
speciation.
Although initial studies have suggested that antioxidant 
supplementation might promote health, however, large 
clinical trials declared no benefi t and even suggested that 
excess supplementation with certain antioxidants might 
be harmful.[40-48] From the literature review it might be 
concluded that supplementation with single antioxidant 
may not be benefi cial, but the diets high in antioxidants 
(fruits and vegetables) are nearly always useful. The 
possible explanation is that, in fruits and vegetables there 
are mixture of antioxidants and it is well recognized that 
they work as a continuous chain, while supplementation is 
usually given using one or two substances. Therefore, the 
antioxidant chain is not completely available.[40-48] In this 
situation, aĞ er scavenging free radicals, if an antioxidant 
is not restored by the following suitable antioxidant 
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in the chain, it begins to be a pro-oxidant. Hence, the 
fi nal eﬀ ect of such supplementations would be no eﬀ ect 
or damaging.[40-49] Therefore, in antioxidant therapy 
complimentary antioxidants cannot always substitute 
the fruits and vegetables high in antioxidants. However, 
consumption of vegetable and fruits as well as medicinal 
plants with high antioxidant content is recommended.[40-50]
MEDICINAL PL ANTS WITH ANTI-DIABETIC 
ACTIVITIES
The results of the studies suggest a trend towards the benefi t 
of consuming vegetables and fruits consumption in DM.[48-51] 
Several studies examining dietary paĴ erns and incidence of 
type 2 diabetes have also shown that vegetables and fruits 
are important components of the dietary paĴ erns associated 
with a decreased risk of type 2 diabetes.[48-52]
A possible benefi t of vegetables and fruit is from their 
antioxidant components and thus a contribution to 
reduction of systemic oxidative stress.[50-53] Vegetables and 
fruits have been shown to contain high concentrations 
of antioxidants, which might reduce the risk of diabetes 
especially type 2 DM. Vegetables and fruits are also good 
sources of α linolenic acid, an omega 3 polyunsaturated 
faĴ y acid.[49-54]
Medicinal plants also have played an important role in 
the management of DM, worldwide [Table 2]. Medicinal 
plants have a long history in the treatment of diseases. 
In traditional medicine, about 800 plants are used for the 
treatment of DM.[50-55]
With rapid advancement of technologies and the increase 
in research on anti-diabetic plants, many new herbs 
and their active principles have been discovered which 
may lead us to develop novel anti-diabetic agents to 
supplement the current chemotherapies. Jung et al. 
(2006) reviewed the hypoglycemic effects of several 
plants with anti-diabetic properties, as well as the plants 
by-products discovered during 2001-2005 having anti-
diabetic actions.[55-57] In this paper, the newly identifi ed 
anti-diabetic plants (2005-2013) are summarized in 
Table 2, in which the reliable hypoglycemic plants are 
included. Although in many cases these agents have the 
same mechanism as synthetic agents act, however, some 
of them may act with a diﬀ erent way. These probable 
mechanisms should be evaluated when searching new 
agents and their mechanisms of actions.
DISCUSSION AND CONCLUSION
Medicinal plants have a long history in the treatment 
of diseases including DM.[50-55] The benefi cial eﬀ ects of 
medicinal plants in DM have been confi rmed in several 
studies.
In this paper, the newly identifi ed anti-diabetic plants 
(2005-2013) were summarized in Table 2. Although in many 
cases the mechanism actions of these agents were presented 
and it was shown that they may have the same mechanism 
as synthetic agents act, however, the exact mechanism 
action of these drugs are poorly established. Hence, more 
works are needed to realize the exact mechanisms of these 
plants.
A possible mechanism and benefit of medicinal plants 
is from their antioxidant activities. Most of medicinal 
plants with anti-diabetic property possess antioxidant 
activity.[50-53] In this regards, it has been confirmed 
that vegetables and fruits, in comparison to synthetic 
antioxidants, are more effective and are able to decrease 
the risk of DM.[48-52]
It has been shown that under stressful conditions free 
radicals are over-produced, inducing oxidative stress. 
Oxidative stress occurs when there is an imbalance 
between free radical formation and antioxidant defense 
capacity.[139-143] This oxidative stress usually causes 
or exacerbates chronic hard curable diseases such as 
diabetes,[144-148] hypertension,[149,150] cardiovascular[151-153] 
cancer,[154-156] cognitive diseases,[157-160] and pain[161-165] 
or exacerbation of some other diseases like infectious 
disorders.[166-172]
Although, in some cases, synthetic antioxidants have also 
been eﬀ ective in reduction of DM, however, in contrast 
to natural antioxidants, synthetic antioxidants usually 
produce side eﬀ ects such as toxicity. Hence, preparation 
of natural products with antioxidant activities with 
property to prevent and treat free radical-associated 
diseases is essential.[172-174] Other than the plants which 
were introduced here, a lot of other plants have antioxidant 
activities.[175-181]
These plants have drawn much attraction because 
they have protective or curative properties against 
most of hard curable diseases such as cognitive deficit, 
memory impairment, cancer, and cardiovascular 
diseases which have been attributed to their antioxidant 
activities.[182-190] Therefore, they also might be effective 
on DM.
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Table 2: Anti-diabetic plants
Extraction 
solvent
Positive 
control
Family Animal model Solvent Positive control Reference
Plant species
Aegle marmelos, Artocarpus 
heterophyllus, Vangueria 
madagascariensis, Azadirachta 
indica, Eriobotrya japonica, 
Syzigium cumini
Poaceae, Rutaceae, 
Moraceae, 
Rubiaceae, 
Meliaceae, Rosaceae
In vitro: a-amylase 
inhibition
Water Glibenclamide (5 mg/kg) [58]
African black tea, Camellia 
sinensis
Theaceae Male KK-AY/TaJcl 
mice (p.o.)
Hot water — [59]
Amaranthus spinosus Amaranthaceae STZ rats (p.o.) Methanol Glibenclamide (5 mg/kg) [60]
Angelica hirsutiﬂ ora Umbelliferae High-fat diet-
induced diabetic 
mice (p.o.)
Methanol Glibenclamide 
(10 mg/kg bw)
[61]
Annona squamosal Annonaceae STZ rats (p.o.) Water Insulin (6 unit kg−1) [62]
Artemisia princeps, Pampanini 
sajabalssuk
Asteraceae C57BL/KsJ-db/db 
mice (p.o.)
Ethanol Rosiglitazone (0.005/100 g 
diet)
[63]
Begonia malabarica Begoniaceae STZ rats (p.o.) Methanol Glibenclamide (5 mg/kg) [64]
Butea monosperma Papilionaceae ALX rats (p.o.) Water and methanol 
extracts
Glibenclamide (0.4 mg/kg) [65]
Caralluma sinaica Asclepiadaceae STZ rabbits (p.o.) Aqueous Glibenclamide (5 mg/kg bw) [66]
Caralluma sinaica Asclepiadaceae STZ rabbits (p.o.) Ethanol Glibenclamide (5 mg/kg) [67]
Cecropia pachystachya Cecropiaceae ALX rats (p.o.) Methanol extract Metformin (120 mg/kg), 
glibenclamide (3 mg/kg)
[68]
Cecropia pachystachya Cecropiaceae ALX rats (p.o.) Methanol Metformin (120 mg/kg), 
glibenclamide (3 mg/kg)
[68]
Cichorium intybus Compositae STZ rats (p.o.) 80% ethanol Metformin (500 mg/kg) [69]
Cinnamomi cassia Lauraceae C57BIKsj db/db 
mice (p.o.)
Water extract 
containing 5% 
cinnamonaldehyde
— [70]
Cinnamomum parthenoxylon Lauraceae STZ rats (p.o.) Polyphenolic 
oligomer-rich
Glymepiride (5 mg/kg bw) [71]
Cleistocalyx operculatus 
Eugenia operculata
Myrtaceae In vitro, 
a-glucosidase; in 
vivo, STZ rats (p.o.)
Aqueous Acarbose (25 mgkg); 
guava leaf extract (500 
mg/kg)
[72]
Clerodendrum capitatum Verbenaceae Normal rats (p.o.) Aqueous — [73]
Cornus mas L. Cornaceae STZ rats (i.p.) 70% ethanol Glibenclamide (5 mg/kg) [74]
Cucurbita pepo Cucurbitaceae STZ rats (i.p) 70% ethanol Glybenclamide (150 mg/kg) [75]
Cymbopogon citratus Graminaceae Normal Wistar rats 
(p.o.)
Aqueous — [76]
Cyperus rotundus Cyperaceae ALX rats (p.o.) 70% ethanol Metformin (450 mg/kg) [77]
Diospyros peregrine Ebenaceae STZ rats (p.o.) Methanol Glibenclamide (1 mg/
kg bw)
[78]
Dryopteris fragrans Aspidiaceae STZ rats (p.o.) Aqueous — [79]
Eriobotrya Japonica Rosaceae ALX rats (p.o.) 70% ethanol extract Phenformin (100 mg/kg) [80]
Eugenia jambolana Myrtaceae ALX rabbit (p.o.) Water; ethanol Tolbutamide 
(250 mg/kg, bw)
[81]
Garuga pinnata Burseraceae STZ rats (p.o.) Water Glibenclamide 
(0.25 mg/kg)
[82]
Genista tenera Fabaceae STZ rats (p.o.) n-butanol Glibenclamide (0.5 mg/
kg bw)
[83]
Heinsia crinata Rubiaceae ALX rats (p.o.) Ethanol Glibenclamide (10 mg/kg) [84]
Helichrysum graveolens Asteraceae STZ rats (p.o.) Aqueous, ethanol Tolbutamide (100 mg/kg) [85]
Helichrysum plicatum Asteraceae STZ rats (p.o.) Aqueous, ethanol Tolbutamide (100 mg/kg) [86]
Helicteres isora Sterculiaceae STZ rat (p.o.) Water Tolbutamide (250 mg/kg) [87]
Heliotropium zeylanicum Boraginaceae STZ rats (p.o.) Methanol; chloroform Tolbutamide (10 mg/kg) [88]
Hemionitis arifolia Hemionitidaceae ALX rats (p.o.) Ethanol extract, 
subsequently ethyl 
acetate fraction
Insulin (5 IU/kg, i.p.) [89]
Hibiscus rosasinensis Malvaceae ALX rats (p.o.) Ethanol Glibenclamide (10 mg/kg) [90]
(Continued)
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Table 2: (Continued)
Extraction 
solvent
Positive 
control
Family Animal model Solvent Positive control Reference
Plant species
Hunteria umbellata Apocynaceae ALX and high 
fructose induced 
hyperglycemic rats 
(p.o.)
Aqueous Glibencalmide (1 mg/kg) [91]
Hypoxis hemerocallidea Hypoxidaceae STZ rats (p.o.) Water Chlorpropamide 
(250 mg/kg p.o.)
[92]
Ichnocarpus frutescence Apocynaceae Normal rats, 
glucose-fed rats, 
STZ rats (p.o.)
Methanol and 
n-hexane extracts
Glibenclamide 
(0.6 mg/kg)
[93]
Indian water lily, Nymphaea 
stellate
Nymphaeaceae ALX rats (p.o.) Ethanol Glibenclamide (2 g/kg) [94]
Indigofera mysorensis Fabaceae C57BL/KsJ-db/db 
mice (p.o.)
Ethanol Rosiglitazone (0.005/ 
100 g diet)
[95]
Juglans regia Juglandaceae ALX rats (i.p.) Ethanol Glibenclamide 
(0.6 mg/kg)
[96]
Juniperus chinensis Cupressaceae ALX rats (p.o.) Aqueous and ethanol Glibenclamide 
(0.2 mg/kg)
[97]
Kalanchoe crenata Crassulaceae High calories 
sucrose diet (p.o.)
Hydroalcohol Glibenclamide (10 mg/kg) [98]
Laportea ovalifolia (Scham and 
Thonn)
Urticaceae ALX rat (p.o.) Methanol methylene 
chloride (1:1)
Tolbutamide (80 mg/kg) [99]
Leucas cephalotes Lamiaceae ALX rats (IDDM) 
STZ rats (NIDDM) 
(p.o.)
Ethanol Glibenclamide 
(600 mg/kg), metformin 
(500 mg/kg)
[100]
Leucas cephalotes Lamiaceae ALX rats (IDDM), 
STZ rats (NIDDM) 
(p.o.)
Ethanol Metformin (500 mg/kg),
glibenclamide 
(600 mg/kg)
[100]
Liriope spicata Liliaceae STZ mice (p.o.) Water, crude 
polysaccharide 
fraction
Rosiglitazone (2 mg/kg) [101]
Matricaria chamomilla Asteraceae STZ rats (p.o.) Ethanol Glibenclamide (5 mg/kg) [102]
Mucuna pruriens Fabaceae STZ rats (p.o.) Water Tolbutamide (250 mg/kg) [103]
Murraya koenigii, Mentha 
piperitae, Ocimum sanctum, 
Aegle marmelos
Rutaceae, 
Lamiaceae, 
Lamiaceae, 
Rutaceae
STZ rats (p.o.) Ethanol extract — [104]
Musanga cecropioides Urticaceae ALX rats (p.o.) Aqueous, ethanol Metformin (20 mg/kg) [105]
Nigella sativa Ranunculaceae In vitro: Short-
circuit current 
technique; In vivo: 
OGTT in normal rats 
(p.o.)
Aqueous Metformin (300 mg/kg) [106]
Nymphaea stellata Ethanol extract ALX rats (p.o.) Ethanol Metformin (11.3 mg/kg) [107]
Olea europaea Oleaceae STZ rats (p.o.) Ethanol Glibenclamide 
(0.6 mg/kg)
[108]
Orthosiphon stamineus Lamiaceae STZ rats (p.o.) Water Glibenclamide 
(0.5 mg/kg)
[109]
Parinari excels Chrysobalanaceae ALX rats (p.o.) Water Glibenclamide 
(200 mg/kg)
[110]
Parkia biglobosa Mimosaceae ALX rats (p.o.) Ethanol Glibenclamide 
(0.01 mg/150 g bw)
[111]
Parkinsonia aculeata Cesalpineaceae ALX rats (p.o.) Aqueous extract Insulin NPH (3 U rat−1, 
s.c.)
[112]
Phyllanthus amarus Euphorbiaceae Normal swiss mice 
(p.o.)
Aqueous — [113]
Plantago ovata Plantaginaceae STZ rats (p.o.) Aqueous — [114]
Pongamia pinnata Fabacae ALX mice (p.o.) Petroleum Gglyburide (10 mg/kg) [115]
Posidonia oceanica Posidoniaceae ALX rats (p.o.) Aqueous ethanol — [116]
(Continued)
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Table 2: (Continued)
Extraction 
solvent
Positive 
control
Family Animal model Solvent Positive control Reference
Plant species
Prunella vulgaris Lamiaceae STZ rats (p.o.) Hydroalcohol Glibenclamide (5 mg/kg) [117]
Psidium guajava Myrtaceae STZ rats (p.o.) Aqueous ethanol — [118]
Pterocarpus marsupium Leguminosae ALX rats (p.o.) Butanol subfraction 
of alcohol
Phenformin (300 mg/kg) [119]
Rhus chirindensis Anacardiaceae STZ rats (p.o.) Aqueous Chlorpropamide 
(250 mg/kg)
[120]
Rhus verniciﬂ ua, Agrimonia 
pilosa, Sophora japonica, 
Paeonia suffruticosa
Anacardiaceae, 
Rosaceae, 
Fabaceae, 
Paeoniaceae
STZ rats (p.o.) 80% ethanol Green tea extract 
(10 mg/kg)
[121]
Rosa damascena Rosaceae In vitro, 
a-glucosidase; in 
vivo, STZ rats (p.o.)
Methanol Acarbose (50 mg/kg) [122]
Salvia ofﬁ cinalis Lamiaceae Diabetes 70% ethanol Glibenclamide (5 mg/kg) [123]
Schkuhria pinnata, Euclea 
undulate, Elaeodendron 
transvaalense
Asteraceae Ebenaceae 
Celastraceae
In vitro assays: 
aglucosidase 
and amylase 
inhibition in C2C12 
myocytes, 3T3-L1 
preadipocytes and 
Chang liver cells
Acetone/ethanol Insulin (1 mm) [124]
Sclerocarya birrea Anacardiaceae STZ rats (p.o.) Methylene chloride/
methanol
Metformin (500 mg/kg) [125]
Shweta musali (in India), Sutaid 
musk (in Pakistan), Asparagus 
adscendens
Liliacea In vitro clonal 
pancreatic beta cell 
line, BRIN-BD11; 
3T3-L1 adipocytes
Water — [126]
Siberian ginseng, Acanthopanax 
senticosus
Araliaceae Ob/ob mice (p.o.) 50% ethanol Metformin (300 mg/kg) 
108
[127]
Siraitia grosvenori Cucurbitaceae GK Aqueous — [128]
Stachytarpheta angustifoloa Verbanaceae ALX rats (p.o.) Aqueous Metformin (500 mg/kg), 
chlorpropamide (250 mg/kg), 
glibenclamide (1 mg/kg)
[129]
Syzygium cumini Myrtaceae In vitro, 
a-glucosidase; in 
vivo, GK rats (p.o.)
Acetone Acarbose (in vitro); N/A 
(in vivo)
[130]
Tecoma stans Bignoniaceae In vitro, a-glucosidase 
inhibition In vivo, STZ 
rats (p.o.)
Aqueous Acarbose (50 mg/kg), 
tolbutamide (60 mg/kg)
[131]
Terminalia superba, Canarium 
schweinfurthii
Combretaceae; 
Burseraceae
STZ rats (p.o.) Methanol/methylene 
chloride (1:1) extract
Insulin (3 IU) [132]
Tithonia diversifolia Chrysanthemum KK-Ag-mice (p.o.) 80% ethanol Insulin [133]
Tragia cannabina Euphorbiaceae STZ rats (p.o.) Ethanol Glibenclamide 
(0.5 mg/kg)
[134]
Trema micrantha Ulmaceae ALX rats (v.o.) Ethanol Glibenclamide 
(200 mg/kg)
[135]
Tridax procumbens Asteraceae ALX rats (p.o.) 50% methanol extract Glibenclamide (10 mg/kg) [136]
Vernonia anthelmintica Asteraceae STZ rats (p.o.) Ethanol extract 
followed by 
fractionation 
with silica gel 
chromatography
Glibenclamide (20 mg/kg) [137]
Vitex megapotamica Verbenaceae ALX rats (p.o.) Ethanol, hexane, ethyl 
acetate, butanol, 
dichloromethane, 
methanol sub-
fractions
Insulin (0.3 IU); 
tolbutamide (100 mg/kg)
[138]
GK = Goto-Kakizaki; STZ = Streptozotocin; ALX = Alloxan; IDDM = Insulin-dependent diabetes mellitus; NIDDM = Noninsulin dependent diabetes mellitus; OGTT = Oral glucose 
tolerance test; N/A = Not available
Nasri, et al.: Antioxidants and diabetes mellitus
Journal of Research in Medical Sciences| May 2015 | 498
AUTHOR’S CONTRIBUTIONS
HN, HSh, MRK contributed in the design of the work, 
revising the draft, approval of the final version of the 
manuscript, and agreed for all aspects of the work. AB, 
MRK contributed in the design of the work, Editing the 
fi nal version, approval of the fi nal version of the manuscript, 
and agreed for all aspects of the work. All authors wrote 
the manuscript equally.
REFERENCES
1. S hoback D, Gardner DG, editor. Greenspan’s Basic & Clinical 
Endocrinology. 9th ed. Ch. 17. New York: McGraw-Hill Medical; 2011.
2. Nasri H. On the occasion of the world diabetes day 2013; diabetes 
education and prevention; a nephrology point of view. J Renal Inj 
Prev 2013;2:31-2.
3. Shahbazian H. World diabetes day; 2013. J Renal Inj Prev 
2013;2:123-4.
4. Nasri H, Rafi eian-Kopaei M. Herbal medicine and diabetic kidney 
disease. J Nephropharmacol 2013;2:1-2.
5. Tavafi  M. Diabetic nephropathy and antioxidants. J Nephropathol 
2013;2:20-7.
6. Nasri H, Sahinfard N, Rafieian M, Rafieian S, Shirzad M, 
Rafi eian-kopaei M. Eﬀ ects of Allium sativum on liver enzymes and 
atherosclerotic risk factors. J HerbMed Pharmacol 2013;2: 23-8.
7. Tamadon MR, Baradaran A, Rafi eian-Kopaei M. Antioxidant and 
kidney protection; diﬀ erential impacts of single and whole natural 
antioxidants. J Renal Inj Prev 2014;3:41-2.
8. Tolouian R, T Hernandez G. Prediction of diabetic nephropathy: 
The need for a sweet biomarker. J Nephropathol 2013;2:4-5.
9. Nasri H, Yazdani M. The relationship between serum LDL-
cholesterol, HDL-cholesterol and systolic blood pressure in 
patients with type 2 diabetes. Kardiol Pol 2006;64:1364-8.
10. Nasri H, Shirzad H. Toxicity and safety of medicinal plants. J 
HerbMed Plarmacol 2013;2:21-2.
11. Mogharabi M, Abdollahi M, Faramarzi MA. Safety concerns to 
application of graphene compounds in pharmacy and medicine. 
Daru 2014;22:23.
12. Rafi eian-Kopaei M, Baradaran A, Rafi eian M. Plants antioxidants: 
From laboratory to clinic. J Nephropathol 2013;2:152-3.
13. Mardani S, Nasri H, Hajian S, Ahmadi A, Kazemi R, Rafi eian-
Kopaei M. Impact of Momordica charantia extract on kidney 
function and structure in mice. J Nephropathol 2014;3: 35-40.
14. Nasri H. Impact of diabetes mellitus on parathyroid hormone in 
hemodialysis patients. J Parathyr Dis 2013;1:9-11.
15. Rahimi Z, Mansouri Zaveleh O, Rahimi Z, Abbasi A. AT2R-1332 G: 
A polymorphism and diabetic nephropathy in type 2 diabetes 
mellitus patients. J Renal Inj Prev 2013;2:97-101.
16. Ardalan MR, Rafi eian-Kopaei M. Is the safety of herbal medicines 
for kidneys under question? J Nephropharmacol 2013;2:11-2.
17. Roshan B, Stanton RC. A story of microalbuminuria and diabetic 
nephropathy. J Nephropathol 2013;2:234-40.
18. Kafeshani M. Ginger, micro-infl ammation and kidney disease. 
J Renal Endocrinol 2015;1:e04.
19. Nasri H, Behradmanesh S, Ahmadi A, Rafi eian-Kopaei M. 
Impact of oral Vitamin D (cholecalciferol) replacement therapy 
on blood pressure in type 2 diabetes patients; a randomized, 
double-blind, placebo controlled clinical trial. J Nephropathol 
2014;3:29-33.
20. Asadi-Samani M, Bahmani M, Rafi eian-Kopaei M. The chemical 
composition, botanical characteristic and biological activities of 
Borago oﬃ  cinalis: a review. Asian Pac J Trop Med 2014;7(Suppl 
1):22-28.
21. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, 
Bergeonneau C, Kassaï B, et al. Effect of intensive glucose 
lowering treatment on all cause mortality, cardiovascular death, 
and microvascular events in type 2 diabetes: Meta-analysis of 
randomised controlled trials. BMJ 2011;343:d4169.
22. Rafi eian-Kopaei M, Nasri H. Vitamin D therapy in diabetic kidney 
disease. J Nephropharmacol 2014;3:3-4.
23. Bahmani M, Zargaran A, Rafi eian-Kopaei M, Saki M. Ethnobotanical 
study of medicinal plants used in the management of diabetes 
mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med 
2014;7(Suppl 1):348-354.
24. Rouhi H, Ganji F. Eﬀ ects of N-acetyl cysteine on serum lipoprotein 
(a) and proteinuria in type 2 diabetic patients. J Nephropathol 
2013;2:61-6.
25. Rafi eian-Kopaei M, Behradmanesh S, Kheiri S, Nasri H. Association 
of serum uric acid with level of blood pressure in type 2 diabetic 
patients. Iran J Kidney Dis 2014;8:152-4.
26. Ardalan MR, Sanadgol H, Nasri H, Baradaran A, Tamadon MR, 
Rafi eian-Kopaei R. Impact of Vitamin D on the immune system 
in kidney disease. J Parathyr Dis 2013;1:17-20.
27. Ajabshir S, Asif A, Nayer A. The eﬀ ects of Vitamin D on the renin-
angiotensin system. J Nephropathol 2014;3:41-3.
28. Nasri H. Correlation of serum magnesium with serum levels of 
25-hydroxyvitamin D in hemodialysis patients. J Parathyr Dis 
2014;2:11-3.
29. Nasri H, Behradmanesh S, Ahmadi A, Baradaran A, Nasri P, 
Rafi eian-Kopaei M. Association of serum lipids with level of blood 
pressure in type 2 diabetic patients. J Renal Inj Prev 2014;3:43-6.
30. Nasri H, Rafi eian-Kopaei M. Metformin improves diabetic kidney 
disease. J Nephropharmacol 2012;1:1-2.
31. Ayodhya S, Kusum S, Saxena A. Hypoglycaemic activity of 
diﬀ erent extracts of various herbal plants. Int J Res Ayurveda 
Pharm 2010;1:212.
32. Abdollahi M, Farshchi A, Nikfar S, Seyedifar M. Eﬀ ect of chromium 
on glucose and lipid profi les in patients with type 2 diabetes; a 
meta-analysis review of randomized trials. J Pharm Pharm Sci 
2013;16:99-114.
33. Rafi eian-Kopaei M, Nasri H. Ginger and diabetic nephropathy. 
J Renal Inj Prev 2013;2:9-10.
34. Nasri H, Rafieian-Kopaei M. Tubular kidney protection by 
antioxidants. Iran J Public Health 2013;42:1194-6.
35. Ardalan MR, Sanadgol H, Nasri H, Baradaran A, Tamadon MR, 
Rafi eian-Kopaei R. Vitamin D therapy in diabetic kidney disease; 
current knowledge on a public health problem. J Parathyr Dis 
2014;2:15-7.
36. Turdi S, Li Q, Lopez FL, Ren J. Catalase alleviates cardiomyocyte 
dysfunction in diabetes: Role of Akt, Forkhead transcriptional 
factor and silent information regulator 2. Life Sci 2007;81:895-905.
37. Rafi eian-Kopaie M. Metformin and renal injury protection. J Renal 
Inj Prev 2013;2:91-2.
38. Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced 
mortality associated with the use of ACE inhibitors in patients 
with type 2 diabetes. Diabetes Care 2004;27:1330-4.
39. Rafi eian-Kopaei M, Baradaran A. Combination of metformin with 
other antioxidants may increase its renoprotective eﬃ  cacy. J Renal 
Inj Prev 2013;2:35-6.
40. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic 
nephropathy. J Nephropathol 2012;1:143-51.
41. Tavafi  M. Complexity of diabetic nephropathy pathogenesis and 
design of investigations. J Renal Inj Prev 2013;2:59-62.
42. Ghamarian A, Abdollahi M, Su X, Amiri A, Ahadi A, Nowrouzi A. 
Eﬀ ect of chicory seed extract on glucose tolerance test (GTT) 
Nasri, et al.: Antioxidants and diabetes mellitus
Journal of Research in Medical Sciences | May 2015 |499
and metabolic profi le in early and late stage diabetic rats. Daru 
2012;20:56.
43. Song Y, Cook NR, Albert CM, Van Denburgh M, Manson JE. Eﬀ ects 
of Vitamins C and E and beta-carotene on the risk of type 2 diabetes 
in women at high risk of cardiovascular disease: A randomized 
controlled trial. Am J Clin Nutr 2009;90:429-37.
44. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, 
Appel LJ, Guallar E. Meta-analysis: High-dosage Vitamin E 
supplementation may increase all-cause mortality. Ann Intern 
Med 2005;142:37-46.
45. Greenland S. Weaknesses of Bayesian model averaging for meta-
analysis in the study of Vitamin E and mortality. Clin Trials 
2009;6:42-6.
46. Fikree M, Hanafi  B, Hussain ZA, Masuadi EM. Glycemic control 
of type 2 diabetes mellitus. Bahrain Med Bull 2006;28:1-6.
47. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 
1998;17:109-15.
48. Rafi eian-Kopaei M, Baradaran A, Rafi eian M. Oxidative stress 
and the paradoxical effects of antioxidants. J Res Med Sci 
2013;18:629.
49. Hajivandi A, Amiri M. World kidney day 2014: Kidney disease 
and elderly. J Parathyr Dis 2014;2:3-4.
50. Rafi eian-Kopaei M, Baradaran A. Teucrium polium and kidney. 
J Renal Inj Prev 2013;2:3-4.
51. Tamadon MR, Ardalan MR, Nasri H. World kidney day 2013; acute 
renal injury; a global health warning. J Parathyr Dis 2013;1:27-8.
52. Rafi eian-Kopaie M, Nasri H. Silymarin and diabetic nephropathy. 
J Renal Inj Prev 2012;1:3-5.
53. Hulbert AJ, Turner N, Storlien LH, Else PL. Dietary fats and 
membrane function: Implications for metabolism and disease. 
Biol Rev Camb Philos Soc 2005;80:155-69.
54. Nasri H, Behradmanesh S, Maghsoudi AR, Ahmadi A, Nasri P, 
Rafi eian-Kopaei M. Eﬃ  cacy of supplementary Vitamin D on 
improvement of glycemic parameters in patients with type 2 
diabetes mellitus; a randomized double blind clinical trial. J Renal 
Inj Prev 2014;3:31-4.
55. Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH. Recent 
discovery of plant-derived anti-diabetic natural products. Nat 
Prod Rep 2012;29:580-606.
56. Asgari A. Herbal medicines and kidney; friends or foes? 
J Nephropharmacol 2014;3:5-6.
57. Kotowaroo MI, Mahomoodally MF, Gurib-Fakim A, SubraĴ y AH. 
Screening of traditional antidiabetic medicinal plants of Mauritius 
for possible alpha-amylase inhibitory eﬀ ects in vitro. Phytother Res 
2006;20:228-31.
58. Shoji Y, Nakashima H. Glucose-lowering effect of powder 
formulation of African black tea extract in KK-A(y)/TaJcl diabetic 
mouse. Arch Pharm Res 2006;29:786-94.
59. Sangameswaran B, Jayakar B. Anti-diabetic, anti-hyperlipidemic 
and spermatogenic effects of Amaranthus spinosus Linn. on 
streptozotocin-induced diabetic rats. J Nat Med 2008;62:79-82.
60. Leu YL, Chen YW, Yang CY, Huang CF, Lin GH, Tsai KS, et al. 
Extract isolated from Angelica hirsutifl ora with insulin secretagogue 
activity. J Ethnopharmacol 2009;123:208-12.
61. Ajikumaran Nair S, Shylesh BS, Gopakumar B, Subramoniam A. 
Anti-diabetes and hypoglycaemic properties of Hemionitis arifolia 
(Burm.) Moore in rats. J Ethnopharmacol 2006;106:192-7.
62. Jung UJ, Baek NI, Chung HG, Bang MH, Yoo JS, Jeong TS, et al. 
The anti-diabetic eﬀ ects of ethanol extract from two variants of 
Artemisia princeps Pampanini in C57BL/KsJ-db/db mice. Food 
Chem Toxicol 2007;45:2022-9.
63. Pandikumar P, Babu NP, Ignacimuthu S. Hypoglycemic and 
antihyperglycemic eﬀ ect of Begonia malabarica Lam. in normal and 
streptozotocin induced diabetic rats. J Ethnopharmacol 2009;124:111-5.
64. Somani R, Kasture S, Singhai AK. Antidiabetic potential of Butea 
monosperma in rats. Fitoterapia 2006;77:86-90.
65. Krisanapun C, Peungvicha P, Temsiririrkkul R, Wongkrajang Y. 
Aqueous extract of Abutilon indicum Sweet inhibits glucose 
absorption and stimulates insulin secretion in rodents. Nutr Res 
2009;29:579-87.
66. Habibuddin M, Daghriri HA, Humaira T, Al Qahtani MS, Hefzi AA. 
Antidiabetic eﬀ ect of alcoholic extract of Caralluma sinaica L. on 
streptozotocin-induced diabetic rabbits. J Ethnopharmacol 
2008;117:215-20.
67. Aragão DM, Guarize L, Lanini J, da Costa JC, Garcia RM, Scio E. 
Hypoglycemic effects of Cecropia pachystachya in normal and 
alloxan-induced diabetic rats. J Ethnopharmacol 2010;128: 
629-33.
68. Dimo T, Rakotonirina SV, Tan PV, Azay J, Dongo E, Kamtchouing P, 
et al. Effect of Sclerocarya birrea (Anacardiaceae) stem bark 
methylene chloride/methanol extract on streptozotocin-diabetic 
rats. J Ethnopharmacol 2007;110:434-8.
69. Kim SH, Hyun SH, Choung SY. Anti-diabetic eﬀ ect of cinnamon 
extract on blood glucose in db/db mice. J Ethnopharmacol 
2006;104:119-23.
70. Park SH, Ko SK, Choi JG, Chung SH. Salicornia herbacea prevents 
high fat diet-induced hyperglycemia and hyperlipidemia in ICR 
mice. Arch Pharm Res 2006;29:256-64.
71. Mai TT, Chuyen NV. Anti-hyperglycemic activity of an aqueous 
extract from fl ower buds of Cleistocalyx operculatus (Roxb.) Merr 
and Perry. Biosci Biotechnol Biochem 2007;71:69-76.
72. Adeneye AA, Adeleke TI, Adeneye AK. Hypoglycemic and 
hypolipidemic effects of the aqueous fresh leaves extract 
of Clerodendrum capitatum in Wistar rats. J Ethnopharmacol 
2008;116:7-10.
73. Shamsi F, Asgari S, Rafi eian R, Kazemi S. Eﬀ ects of Cornus mas 
L. on blood glucose, insulin and histopathology of pancreas in 
alloxan-induced diabetic rats. J Isfahan Med Sch 2011;29: 927-37.
74. Kazemi S, Asgari S, Moshtaghian SJ, Rafieian-Kopaei M, 
Mahzooni P. Preventive eﬀ ect of Pumpkin (Cucurbita pepo L.) on 
diabetic index and histopathology of pancreas in Alloxan-induced 
diabetes in rats. J Isfahan Med Sch 2011;28:872-81.
75. Adeneye AA, Agbaje EO. Hypoglycemic and hypolipidemic eﬀ ects 
of fresh leaf aqueous extract of Cymbopogon citratus Stapf. in rats. 
J Ethnopharmacol 2007;112:440-4.
76. Raut NA, Gaikwad NJ. Antidiabetic activity of hydro-ethanolic 
extract of Cyperus rotundus in alloxan induced diabetes in rats. 
Fitoterapia 2006;77:585-8.
77. Dewanjee S, Das AK, Sahu R, Gangopadhyay M. Antidiabetic 
activity of Diospyros peregrina fruit: Eﬀ ect on hyperglycemia, 
hyperlipidemia and augmented oxidative stress in experimental 
type 2 diabetes. Food Chem Toxicol 2009;47:2679-85.
78. Khookhor O, Bolin Q, Oshida Y, Sato Y. Eﬀ ect of Mongolian plants 
on in vivo insulin action in diabetic rats. Diabetes Res Clin Pract 
2007;75:135-40.
79. Li WL, Wu JL, Ren BR, Chen J, Lu CG. Pharmacological studies on 
anti-hyperglycemic eﬀ ect of folium eriobotryae. Am J Chin Med 
2007;35:705-11.
80. Sharma SB, Nasir A, Prabhu KM, Murthy PS. Antihyperglycemic 
eﬀ ect of the fruit-pulp of Eugenia jambolana in experimental 
diabetes mellitus. J Ethnopharmacol 2006;104:367-73.
81. Shirwaikar A, Rajendran K, Barik R. Eﬀ ect of aqueous bark extract 
of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced 
type-II diabetes mellitus. J Ethnopharmacol 2006;107:285-90.
82. Rauter AP, Martins A, Lopes R, Ferreira J, Serralheiro LM, 
Araújo ME, et al. Bioactivity studies and chemical profile of 
the antidiabetic plant Genista tenera. J Ethnopharmacol 2009; 
122:384-93.
Nasri, et al.: Antioxidants and diabetes mellitus
Journal of Research in Medical Sciences| May 2015 | 500
83. Okokon JE, Umoh EE, Etim EI, Jackson CL. Antiplasmodial and 
antidiabetic activities of ethanolic leaf extract of Heinsia crinata. 
J Med Food 2009;12:131-6.
84. Aslan M, Orhan DD, Orhan N, Sezik E, Yeşilada E. A study of 
antidiabetic and antioxidant eﬀ ects of Helichrysum graveolens 
capitulums in streptozotocin-induced diabetic rats. J Med Food 
2007;10:396-400.
85. Aslan M, Deliorman Orhan D, Orhan N, Sezik E, Yesilada E. In vivo 
antidiabetic and antioxidant potential of Helichrysum plicatum 
ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. 
J Ethnopharmacol 2007;109:54-9.
86. Kumar G, Banu GS, Murugesan AG, Pandian MR. Hypoglycaemic 
eﬀ ect of Helicteres isora bark extract in rats. J Ethnopharmacol 
2006;107:304-7.
87. Murugesh K, Yeligar V, Dash DK, Sengupta P, Maiti BC, Maity TK. 
Antidiabetic, antioxidant and antihyperlipidemic status of 
Heliotropium zeylanicum extract on streptozotocin-induced diabetes 
in rats. Biol Pharm Bull 2006;29:2202-5.
88. Kamtchouing P, Kahpui SM, Dzeufi et PD, Tédong L, Asongalem EA, 
Dimo T. Anti-diabetic activity of methanol/methylene chloride 
stem bark extracts of Terminalia superba and Canarium schweinfurthii 
on streptozotocin-induced diabetic rats. J Ethnopharmacol 
2006;104:306-9.
89. Venkatesh S, Thilagavathi J, Shyam Sundar D. Anti-diabetic activity 
of fl owers of Hibiscus rosasinensis. Fitoterapia 2008;79:79-81.
90. Adeneye  AA,  Adeyemi  OO.  Further  evaluat ion  of 
antihyperglycaemic activity of Hunteria umbellata (K. Schum) 
Hallier f. seed extract in experimental diabetes. J Ethnopharmacol 
2009;126:238-43.
91. Ojewole JA. Antinociceptive, anti-infl ammatory and antidiabetic 
properties of Hypoxis hemerocallidea Fisch. & C.A. Mey.
(Hypoxidaceae) corm [‘African Potato’] aqueous extract in mice 
and rats. J Ethnopharmacol 2006;103:126-34.
92. Subash-Babu P, Ignacimuthu S, Agastian P. Insulin secretagogue 
eﬀ ect of Ichnocarpus frutescence leaf extract in experimental 
diabetes: A dose-dependent study. Chem Biol Interact 2008;172: 
159-71.
93. Ra jagopal  K ,  Sas ika la  K.  Ant ihyperglycaemic  and 
antihyperlipidaemic eﬀ ects of Nymphaea stellata in alloxan-induced 
diabetic rats. Singapore Med J 2008;49:137-41.
94. Chakrabarti R, Damarla RK, Mullangi R, Sharma VM, 
Vikramadithyan RK, Rajagopalan R. Insulin sensitizing 
property of Indigofera mysorensis extract. J Ethnopharmacol 2006; 
105:102-6.
95. Asgary S, Parkhideh S, Solhpour A, Madani H, Mahzouni P, 
Rahimi P. Eﬀ ect of ethanolic extract of Juglans regia L. on blood 
sugar in diabetes-induced rats. J Med Food 2008;11:533-8.
96. Ju JB, Kim JS, Choi CW, Lee HK, Oh TK, Kim SC. Comparison 
between ethanolic and aqueous extracts from Chinese juniper 
berries for hypoglycaemic and hypolipidemic eﬀ ects in alloxan-
induced diabetic rats. J Ethnopharmacol 2008;115:110-5.
97. Kamgang R, Mboumi RY, Fondjo AF, Tagne MA, N’dillé GP, 
Yonkeu JN. Antihyperglycaemic potential of the water-ethanol 
extract of Kalanchoe crenata (Crassulaceae). J Nat Med 2008;62:34-40.
98. Momo CE, Oben JE, Tazoo D, Dongo E. Antidiabetic and 
hypolipidaemic eﬀ ects of a methanol/methylene-chloride extract 
of Laportea ovalifolia (Urticaceae), measured in rats with alloxan-
induced diabetes. Ann Trop Med Parasitol 2006;100:69-74.
99. Bavarva JH, Narasimhacharya AV. Leucas cephalotes regulates 
carbohydrate and lipid metabolism and improves antioxidant 
status in IDDM and NIDDM rats. J Ethnopharmacol 2010;127: 
98-102.
100. Chen X, Bai X, Liu Y, Tian L, Zhou J, Zhou Q, et al. Anti-diabetic 
eﬀ ects of water extract and crude polysaccharides from tuberous 
root of Liriope spicata var. prolifera in mice. J Ethnopharmacol 
2009;122:205-9.
101. Cemek M, Kaga S, Simsek N, Büyükokuroglu ME, Konuk M. 
Antihyperglycemic and antioxidative potential of Matricaria 
chamomilla L. in streptozotocin-induced diabetic rats. J Nat Med 
2008;62:284-93.
102. Bhaskar A, Vidhya VG, Ramya M. Hypoglycemic eﬀ ect of Mucuna 
pruriens seed extract on normal and streptozotocin-diabetic rats. 
Fitoterapia 2008;79:539-43.
103. Narendhirakannan RT, Subramanian S, Kandaswamy M. 
Biochemical evaluation of antidiabetogenic properties of some 
commonly used Indian plants on streptozotocin-induced 
diabetes in experimental rats. Clin Exp Pharmacol Physiol 
2006;33:1150-7.
104. Adeneye AA, Ajagbonna OP, Ayodele OW. Hypoglycemic and 
antidiabetic activities on the stem bark aqueous and ethanol 
extracts of Musanga cecropioides in normal and alloxan-induced 
diabetic rats. Fitoterapia 2007;78:502-5.
105. Meddah B, Ducroc R, El Abbes Faouzi M, Eto B, Mahraoui L, 
Benhaddou-Andaloussi A, et al. Nigella sativa inhibits intestinal 
glucose absorption and improves glucose tolerance in rats. 
J Ethnopharmacol 2009;121:419-24.
106. Dhanabal SP, Raja MK, Ramanathan M, Suresh B. Hypoglycemic 
activity of Nymphaea stellata leaves ethanolic extract in alloxan 
induced diabetic rats. Fitoterapia 2007;78:288-91.
107. Eidi A, Eidi M, Darzi R. Antidiabetic eﬀ ect of Olea europaea L. in 
normal and diabetic rats. Phytother Res 2009;23:347-50.
108. Sriplang K, AdisakwaĴ ana S, Rungsipipat A, Yibchok-Anun S. 
Eﬀ ects of Orthosiphon stamineus aqueous extract on plasma glucose 
concentration and lipid profi le in normal and streptozotocin-
induced diabetic rats. J Ethnopharmacol 2007;109:510-4.
109. Ndiaye M, Diatta W, Sy AN, Dièye AM, Faye B, Bassène E. 
Antidiabetic properties of aqueous barks extract of Parinari excelsa 
in alloxan-induced diabetic rats. Fitoterapia 2008;79:267-70.
110. Odetola AA, Akinloye O, Egunjobi C, Adekunle WA, Ayoola AO. 
Possible antidiabetic and antihyperlipidaemic eﬀ ect of fermented 
Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats. 
Clin Exp Pharmacol Physiol 2006;33:808-12.
111. Oliveira HC, dos Santos MP, Grigulo R, Lima LL, Martins DT, 
Lima JC, et al. Antidiabetic activity of Vatairea macrocarpa extract 
in rats. J Ethnopharmacol 2008;115:515-9.
112. Adeneye AA, Amole OO, Adeneye AK. Hypoglycemic and 
hypocholesterolemic activities of the aqueous leaf and seed extract 
of Phyllanthus amarus in mice. Fitoterapia 2006;77:511-4.
113. Hannan JM, Ali L, Khaleque J, Akhter M, Flatt PR, Abdel-
Wahab YH. Aqueous extracts of husks of Plantago ovata reduce 
hyperglycaemia in type 1 and type 2 diabetes by inhibition of 
intestinal glucose absorption. Br J Nutr 2006;96:131-7.
114. Badole SL, Bodhankar SL. Investigation of antihyperglycaemic 
activity of aqueous and petroleum ether extract of stem bark 
of Pongamia pinnata on serum glucose level in diabetic mice. 
J Ethnopharmacol 2009;123:115-20.
115. Gokce G, Haznedaroglu MZ. Evaluation of antidiabetic, 
antioxidant and vasoprotective eﬀ ects of Posidonia oceanica extract. 
J Ethnopharmacol 2008;115:122-30.
116. Zheng J, He J, Ji B, Li Y, Zhang X. Antihyperglycemic activity of 
Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia 
Pac J Clin Nutr 2007;16 Suppl 1:427-31.
117. Shen SC, Cheng FC, Wu NJ. Eﬀ ect of guava (Psidium guajava Linn.) 
leaf soluble solids on glucose metabolism in type 2 diabetic rats. 
Phytother Res 2008;22:1458-64.
118. Dhanabal SP, Kokate CK, Ramanathan M, Kumar EP, Suresh B. 
Hypoglycaemic activity of Pterocarpus marsupium Roxb. Phytother 
Res 2006;20:4-8.
Nasri, et al.: Antioxidants and diabetes mellitus
Journal of Research in Medical Sciences | May 2015 |501
119. Ojewole JA. Analgesic, anti-infl ammatory and hypoglycaemic 
eﬀ ects of Rhus chirindensis (Baker F.) [Anacardiaceae] stem-bark 
aqueous extract in mice and rats. J Ethnopharmacol 2007;113: 
338-45.
120. Gholamhoseinian A, Fallah H, Sharifi  far F. Inhibitory eﬀ ect 
of methanol extract of Rosa damascena Mill. fl owers on alpha-
glucosidase activity and postprandial hyperglycemia in normal 
and diabetic rats. Phytomedicine 2009;16:935-41.
121. Lima CF, Azevedo MF, Araujo R, Fernandes-Ferreira M, Pereira-
Wilson C. Metformin-like eﬀ ect of Salvia oﬃ  cinalis (common sage): 
Is it useful in diabetes prevention? Br J Nutr 2006;96:326-33.
122. Deutschländer MS, van de Venter M, Roux S, Louw J, Lall N. 
Hypoglycaemic activity of four plant extracts traditionally used 
in South Africa for diabetes. J Ethnopharmacol 2009;124:619-24.
123. Behradmanesh S, Derees F, Rafi eian-kopaei M. Eﬀ ect of Salvia 
oﬃ  cinalis on diabetic patients. J Ren Inj Prev 2013; 2(2):51-54. DOI: 
10.12861/jrip.2013.18.
124. Dimo T, Rakotonirina SV, Tan PV, Azay J, Dongo E, Kamtchouing P, 
et al. Eﬀ ect of Sclerocarya birrea (Anacardiaceae) stem bark methylene 
chloride/methanol extract on streptozotocin-diabetic rats. 
J Ethnopharmacol 2007;110:434-8.
125. Mathews JN, FlaĴ  PR, Abdel-Wahab YH. Asparagus adscendens 
(Shweta musali) stimulates insulin secretion, insulin action and 
inhibits starch digestion. Br J Nutr 2006;95:576-81.
126. Park SH, Lee SG, Kang SK, Chung SH. Acanthopanax senticosus 
reverses faĴ y liver disease and hyperglycemia in ob/ob mice. Arch 
Pharm Res 2006;29:768-76.
127. Suzuki YA, Tomoda M, Murata Y, Inui H, Sugiura M, Nakano Y. 
Antidiabetic eﬀ ect of long-term supplementation with Siraitia 
grosvenori on the spontaneously diabetic Goto-Kakizaki rat. Br J 
Nutr 2007;97:770-5.
128. Isah AB, Ibrahim YK, Abdulrahman EM, Ibrahim MA. The 
hypoglycaemic activity of the aqueous extract of Stachytarpheta 
angustifolia (Verbanaceae) in normoglycaemic and alloxan-
induced diabetic rats. Pak J Biol Sci 2007;10:137-41.
129. Shinde J, Taldone T, BarleĴ a M, Kunaparaju N, Hu B, Kumar S, 
et al. Alpha-glucosidase inhibitory activity of Syzygium cumini 
(Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. 
Carbohydr Res 2008;343:1278-81.
130. Aguilar-Santamaría L, Ramírez G, Nicasio P, Alegría-Reyes C, 
Herrera-Arellano A. Antidiabetic activities of Tecoma stans (L.) 
Juss. ex Kunth. J Ethnopharmacol 2009;124:284-8.
131. Kamtchouing P, Kahpui SM, Dzeufi et PD, Tédong L, Asongalem EA, 
Dimo T. Anti-diabetic activity of methanol/methylene chloride 
stem bark extracts of Terminalia superba and Canarium schweinfurthii 
on streptozotocin-induced diabetic rats. J Ethnopharmacol 
2006;104:306-9.
132. Miura T, Furuta K, Yasuda A, Iwamoto N, Kato M, Ishihara E, et 
al. Antidiabetic eﬀ ect of nitobegiku in KK-Ay diabetic mice. Am J 
Chin Med 2002;30:81-6.
133. Sivajothi V, Dey A, Jayakar B, Rajkapoor B. Antihyperglycemic 
property of Tragia cannabina in streptozotocin-induced diabetic 
rats. J Med Food 2007;10:361-5.
134. Schoenfelder T, Cirimbelli TM, Citadini-ZaneĴ e V. Acute eﬀ ect 
of Trema micrantha (Ulmaceae) on serum glucose levels in normal 
and diabetic rats. J Ethnopharmacol 2006;107:456-9.
135. Pareek H, Sharma S, Khajja BS, Jain K, Jain GC. Evaluation 
of hypoglycemic and anti-hyperglycemic potential of Tridax 
procumbens (Linn.). BMC Complement Altern Med 2009;9:48.
136. Fatima SS, Rajasekhar MD, Kumar KV, Kumar MT, Babu KR, 
Rao CA. Antidiabetic and antihyperlipidemic activity of ethyl 
acetate: Isopropanol (1:1) fraction of Vernonia anthelmintica seeds 
in streptozotocin induced diabetic rats. Food Chem Toxicol 
2010;48:495-501.
137. ZanaĴ a L, de Sousa E, Cazarolli LH, Junior AC, PizzolaĴ i MG, 
Szpoganicz B, et al. Eﬀ ect of crude extract and fractions from Vitex 
megapotamica leaves on hyperglycemia in alloxan-diabetic rats. 
J Ethnopharmacol 2007;109:151-5.
138. Amiri M, Motamedi P, Vakili L, Dehghani N, Kiani F, Taheri Z, et al. 
Beyond the liver protective eﬃ  cacy of silymarin; bright renoprotective 
eﬀ ect on diabetic kidney disease. J Nephropharmacol 2014;3:25-6. 
139. Wiernsperger N. Metformin as a cellular protector; a synoptic view 
of modern evidences. J Nephropharmacol 2015;4:31-36.
140. Nasri H, Rafi eian-Kopaei M. Medicinal plants and antioxidants: 
Why they are not always beneficial? Iran J Public Health 
2014;43:255-7.
141. Hajian S, Rafi eian-Kopaei M, Nasri H. Renoprotective eﬀ ects of 
antioxidants against cisplatin nephrotoxicity. J Nephropharmacol 
2014;3:39-42.
142. Madihi Y, Merrikhi A, Baradaran A, Rafieian-Kopaei M, 
Shahinfard N, Ansari R, et al. Impact of sumac on postprandial 
high-fat oxidative stress. Pak J Med Sci 2013;29:340-5.
143. Beladi-Mousavi SS, Bashardoust B, Nasri H, Ahmadi A, Tolou-
Ghamari Z, Hajian S, et al. The theme of the world diabetes day 
2014; healthy living and diabetes; a nephrology view point. 
J Nephropharmacol 2014;3:43-5.
144. Karimi A, Majlesi M, Rafi eian-Kopaei M. Herbal versus synthetic 
drugs; beliefs and facts. J Nephropharmacol 2015;4:27-30.
145. Rafi eian-Kopaei M, Nasri H. The ameliorative eﬀ ect of Zingiber 
officinale in diabetic nephropathy. Iran Red Crescent Med J 
2014;16:e11324.
146. Nazar CM. Mechanism of hypertension in diabetic nephropathy. 
J Nephropharmacol 2014;3:49-55.
147. Asgary  S ,  Sahebkar  A ,  Afshani  MR,  Keshvar i  M, 
Haghjooyjavanmard S, Rafi eian-Kopaei M. Clinical evaluation 
of blood pressure lowering, endothelial function improving, 
hypolipidemic and anti-infl ammatory eﬀ ects of pomegranate juice 
in hypertensive subjects. Phytother Res 2014;28:193-9.
148. Baradaran A, Nasri H, Rafieian-Kopaei M. Oxidative stress 
and hypertension: Possibility of hypertension therapy with 
antioxidants. J Res Med Sci 2014;19:358-67.
149. Nasri H. The awareness of chronic kidney disease and aging; the 
focus of world kidney day in 2014. J Nephropharmacol 2014;3:1-2.
150. Tavafi  M. Suggestions for aĴ enuation of renal ischemia reperfusion 
injury based on mechanisms involved in epithelial cells damages. 
J Nephropharmacol 2015;4:1-3.
151. Madihi Y, Merrikhi A, Baradaran A, Ghobadi S, Shahinfard N, 
Ansari R, et al. Bioactive components and the eﬀ ect of hydroalcoholic 
extract of Vaccinium myrtillus on postprandial atherosclerosis risk 
factors in rabbits. Pak J Med Sci 2013;29 1 Suppl:384-9.
152. Setorki M, Rafi eian-Kopaei M, Merikhi A, Heidarian E, Shahinfard N, 
Ansari R, et al. Suppressive impact of anethum graveolens 
consumption on biochemical risk factors of atherosclerosis in 
hypercholesterolemic rabbits. Int J Prev Med 2013;4:889-95.
153. Shirzad H, Shahrani M, Rafieian-Kopaei M. Comparison of 
morphine and tramadol eﬀ ects on phagocytic activity of mice 
peritoneal phagocytes in vivo. Int Immunopharmacol 2009;9: 968-70.
154. Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between 
antioxidant activity of garlic extracts and WEHI-164 fi brosarcoma 
tumor growth in BALB/c mice. J Med Food 2011;14:969-74.
155. Shirzad H, Kiani M, Shirzad M. Impacts of tomato extract on the 
mice fi brosarcoma cells. J HerbMed Pharmacol 2013;2:13-6.
156. Baradaran A, Rabiei Z, Rafi eian M, Shirzad H. A review study on 
medicinal plants aﬀ ecting amnesia through cholinergic system. 
J HerbMed Pharmacol 2012;1:3-9.
157. R abiei Z, Hojjati M, Rafi eian-Kopaei M, Alibabaei Z. Eﬀ ect of 
Cyperus rotundus tubers ethanolic extract on learning and memory 
in animal model of Alzheimer. Biomed Aging Pathol 2013;3:185-91.
Nasri, et al.: Antioxidants and diabetes mellitus
Journal of Research in Medical Sciences| May 2015 | 502
158. Rafi eian-Kopaei M, Shahinfard N, Rouhi-Boroujeni H, Gharipour 
M, Darvishzadeh-Boroujeni P. Effects of Ferulago angulata 
extract on serum lipids and lipid peroxidation. Evidence-Based 
Complementary and Alternative Medicine; 2014 (2014), Article ID 
680856, 4 pages hĴ p://dx.doi.org/10.1155/2014/680856.
159. Rabiei Z, Rafi eian-Kopaei M, Mokhtari S, Alibabaei Z, Shahrani M. 
The effect of pretreatment with different doses of Lavandula 
oﬃ  cinalis ethanolic extract on memory, learning and nociception. 
Biomed Aging Pathol 2014;4:71-6.
160. Bahmani M, Rafi eian M, Baradaran A, Rafi eian S, Rafi eian-Kopaei M. 
Nephrotoxicity and hepatotoxicity evaluation of Crocus sativus 
stigmas in neonates of nursing mice. J Nephropathol 2014;3:81-5.
161. Delfan B, Bahmani M, Rafi eian-Kopaei M, Delfan M, Saki K. A 
review study on ethnobotanical study of medicinal plants used 
in relief of toothache in Lorestan Province, Iran. Asian Pac J Trop 
Dis 2014;4 Suppl 2:879-84.
162. Saki K, Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, 
Dehghan K, Bahmani F, et al. The most common native medicinal 
plants used for psychiatric and neurological disorders in Urmia 
city, northwest of Iran. Asian Pac J Trop Dis 2014;4 Suppl 2:895-901.
163. Chandra A, Biersmith M, Tolouian R. Obesity and kidney 
protection. J Nephropathol 2014;3:91-7.
164. Nasri H, Rafi eian-Kopaei M. Oxidative stress and aging prevention. 
Int J Prev Med 2013;4:1101-2.
165. Bagheri N, Rahimian GH, Salimzadeh L, Azadegan F, Rafi eian-
Kopaei M, Taghikhani A, et al. Association of the virulence factors 
of Helicobacter pylori and gastric mucosal interleukin-17/23 mRNA 
expression in dyspeptic patients. EXCLI J 2013;12:5-14.
166. Tamadon MR, Zahmatkesh M, Beladi Mousavi SS. Administration 
of antioxidants in chronic kidney disease. J Nephropharmacol 
2015;4:9-11.
167. Bagheri N, Taghikhani A, Rahimian G, Salimzadeh L, Azadegan 
Dehkordi F, Zandi F, et al. Association between virulence factors 
of Helicobacter pylori and gastric mucosal interleukin-18 mRNA 
expression in dyspeptic patients. Microb Pathog 2013;65:7-13.
168. Tavakoli  M. Kidney protective effects of melatonin. 
J Nephropharmacol 2014;3:7-8.
169. Amirmohammadi M, Khajoenia S, Bahmani M, Rafi eian-Kopaei M, 
EĞ ekhari Z, Qorbani M. In vivo evaluation of antiparasitic eﬀ ects 
of Artemisia abrotanum and Salvia oﬃ  cinalis extracts on Syphacia 
obvelata, Aspiculoris tetrapetra and Hymenolepis nana parasites. 
Asian Pac J Trop Dis 2014;4 Suppl 1:S250-4.
170. Motamedi P, Dehghani N, Kiani F, Taheri Z, Torkamaneh S, Nasri H. 
New concepts in diabetic kidney disease. J Nephropharmacol 
2015;4:47-8.
171. Rahimian G, Sanei MH, Shirzad H, Azadegan-Dehkordi F, 
Taghikhani A, Salimzadeh L, et al. Virulence factors of Helicobacter 
pylori vacA increase markedly gastric mucosal TGF-ß1 mRNA 
expression in gastritis patients. Microb Pathog 2014;67-68:1-7.
172. Baradaran A, Nasri H, Nematbakhsh M, Rafi eian-Kopaei M. 
Antioxidant activity and preventive eﬀ ect of aqueous leaf extract 
of Aloe vera on gentamicin-induced nephrotoxicity in male Wistar 
rats. Clin Ter 2014;165:7-11.
173. Rafieian-Kopaei M, Motamedi P, Vakili L, Dehghani N, 
Kiani F, Taheri Z, et al. Green tea and type 2 diabetes mellitus. 
J Nephropharmacol 2014;3:21-3.
174. Nasri H. Consequences of hypomagnesemia in type 2 diabetes 
mellitus patients. J Renal Inj Prev 2014;3:99-100.
175. Rafieian-Kopaei M, Nasri H. Re: Erythropoietin ameliorates 
oxidative stress and tissue injury following renal ischemia/
reperfusion in rat kidney and lung. Med Princ Pract 2014;23:95.
176. Baradaran A, Nasri H, Rafi eian-Kopaei M. Comment on: Anti-
oxidative stress activity of Stachys lavandulifolia aqueous extract 
in humans. Cell J 2013;15:272-3.
177. Baradaran A, Madihi Y, Merrikhi A, Rafieian-Kopaei M, 
Nematbakhsh M, Asgari A, et al. Nephrotoxicity of hydroalcoholic 
extract of Teucrium polium in Wistar rats. Pak J Med Sci 2013;29 1 
Suppl:329-33.
178. Amini FG, Rafi eian-Kopaei M, Nematbakhsh M, Baradaran A, 
Nasri H. Ameliorative eﬀ ects of metformin on renal histologic 
and biochemical alterations of gentamicin-induced renal toxicity 
in Wistar rats. J Res Med Sci 2012;17:621-5.
179. Ghaderian SB, Beladi-Mousavi SS. The role of diabetes mellitus 
and hypertension in chronic kidney disease. J Renal Inj Prev 
2014;3:109-10.
180. Taheri Z, Ghafari M, Hajivandi A, Amiri M. Vitamin D defi ciency 
in children and adolescents; an international challenge. J Parathyr 
Dis 2014;2:27-31.
181. Bahmani M, Zargaran A, Rafieian-Kopaei M. Identification 
of medicinal plants of Urmia for treatment of gastrointestinal 
disorders. Rev Bras Farmacognosia 2014;24:468-80.
182. Taghikhani A, Afrough H, Ansari-Samani R, Shahinfard N, 
Rafi eian-Kopaei M. Assessing the toxic eﬀ ects of hydroalcoholic 
extract of Stachys lavandulifolia Vahl on rat’s liver. Bratisl Lek Listy 
2014;115:121-4.
183. Heidarian E, Rafi eian-Kopaei M. Protective eﬀ ect of artichoke 
(Cynara scolymus) leaf extract against lead toxicity in rat. Pharm 
Biol 2013;51:1104-9.
184. Rafi eian-Kopaei M, Hosseini M, Shirzad H. Comment on: Eﬀ ect of 
pomegranate fl ower extract oncis platin-induced nephrotoxicity 
in rats. J Nephropathol 2014;3:121-3.
185. Beladi-Mousavi SS, Bashardoust B, Nasri H, Ahmadi A, Hajian S, 
Torkamaneh S. Association of serum magnesium with Vitamin D 
level in normal and renal disease patients. J Parathyr Dis 
2014;2:45-6.
186. Asadi SY,  Parsaei  P,  Karimi M, Ezzati  S,  Zamiri  A, 
Mohammadizadeh F, et al. Eﬀ ect of green tea (Camellia sinensis) 
extract on healing process of surgical wounds in rat. Int J Surg 
2013;11:332-7.
187. Rahimi Z. Parathyroid hormone, glucose metabolism and diabetes 
mellitus. J Parathyr Dis 2014;2:55-6.
188. Gohari AR, Saeidnia S. The role of herbal medicines in treatment 
of urinary tract diseases. J Nephropharmacol 2014;3:13-4.
189. Nazar CM. Diabetic nephropathy; principles of diagnosis 
and treatment of diabetic kidney disease. J Nephropharmacol 
2014;3:15-20.
190. Rafi eian-Kopaei M, Baradaran A. On the occasion of world diabetes 
day 2105; act today to change tomorrow. J Renal Endocrinol 
2015;1:e02.
Source of Support: Nil, Confl icts of Interest: None declared.
